Stock VIVE VIVESTO AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Vivesto AB

Equities

VIVE

SE0000722365

Pharmaceuticals

Delayed Nasdaq Stockholm
Other stock markets
 07:55:08 2024-04-23 am EDT 		5-day change 1st Jan Change
0.301 SEK -2.27% Intraday chart for Vivesto AB -0.33% -26.13%
Mar. 26 Transcript : Vivesto AB - Special Call
Mar. 07 Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial CI

Business Summary

Vivesto AB, formerly Oasmia Pharmaceutical AB is a Swecen-based pharma company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company has a growing portfolio of projects in the clinical phase focused on advanced cancer. Apealea (paclitaxel micellar) is being developed for patients with ovarian cancer through a partnership with Elevar Therapeutics, Inc. Other development programs include Cantrixil, a clinical program in advanced ovarian cancer, and docetaxel micellar, which is being developed for widespread prostate cancer. Vivesto's patented technology platform is developed to improve the water solubility, efficacy and safety of drugs.

Number of employees: 14

Sales per Business

SEK in Million2021Weight2022Weight Delta
Pharmaceutical Products
100.0 %
26 100.0 % 1 100.0 % -96.12%

Sales per region

SEK in Million2021Weight2022Weight Delta
Other Countries
100.0 %
-- 1 100.0 % -

Managers

Managers TitleAgeSince
Erik Kinnman CEO
 Chief Executive Officer 66 23-01-22
Robert Maiorana DFI
 Director of Finance/CFO 64 20-11-30
Heidi Ramstad CTO
 Chief Tech/Sci/R&D Officer 55 21-02-28
Johanna Röstin LAW
 General Counsel 57 21-09-30

Members of the board

Members of the board TitleAgeSince
Isak Peter Zonabend CHM
 Chairman 44 19-03-18
Hege Hellstrom BRD
 Director/Board Member 59 19-09-25
Pål Ryfors BRD
 Director/Board Member 41 22-05-24
Roger Tell BRD
 Director/Board Member 59 22-05-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 538,043,000 330,469,658 ( 61.42 %) 0 61.42 %

Shareholders

NameEquities%Valuation
OP Asset Management Ltd.
0.2672 %
1,437,868 0.2672 % 41 756 kr
Storebrand Asset Management AS
0.0817 %
439,703 0.0817 % 12 769 kr
Case Kapitalförvaltning AB
0.0178 %
95,832 0.0178 % 2 783 kr
Gustavia Fonder AB
0.0118 %
63,286 0.0118 % 1 838 kr
Coeli Asset Management AB
0.005675 %
30,535 0.005675 % 887 kr
Evli Fund Management Co. Ltd.
0.005326 %
28,656 0.005326 % 832 kr

Company contact information

Vivesto AB

Box 3061

169 03, Solna

+46 18 50 54 40

http://www.oasmia.com
address Vivesto AB(VIVE)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
VIVESTO AB Stock Vivesto AB
-24.42% 15.18M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.46% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.38% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.86% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.44% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.34% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.13% 215B
NOVARTIS AG Stock Novartis AG
+2.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-7.65% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.79% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VIVE Stock
  4. Company Vivesto AB